Xifaxan
Product Images NDC 54868-5972

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Xifaxan (NDC 54868-5972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xifaxan 200 mg Tablets Label (5972)

XIFAXAN 200 mg tablets packaging label by Physicians Total Care, Inc. Contains 3 tablets per bottle. The label includes dosage and storage information, cautions such as federal law prohibiting dispensing without prescription, and directions to keep the medication out of reach of children.*

FDA Label Image

Xifaxan 550 mg Tablets Label (6154)

XIFAXAN 550 mg tablets label from Physicians Total Care, Inc. The label indicates the product contains 9 tablets of rifaximin, with warnings about federal law restricting dispensing without a prescription, storage instructions, and a caution to keep out of reach of children. The label includes a barcode, lot number, manufacture and expiration dates, and recommends storing at controlled room temperature.*

FDA Label Image

Xifaxan Structural Formula (Xifaxan 1)

Chemical structure of the active ingredient in XIFAXAN. The structure shows a complex ring system with multiple hydroxyl, methyl, and other functional groups characteristic of its molecular composition.*

FDA Label Image

Kaplan-meier Event-free Curves Graph (Xifaxan 2)

A survival curve graph comparing the proportion of patients without breakthrough hepatic encephalopathy (HE) over days post-randomization between XIFAXAN and placebo groups. The XIFAXAN group shows a higher proportion over time. The graph includes a hazard ratio, confidence interval, and statistical significance (log-rank p-value).*

FDA Label Image

Kaplan-meier Event-free Curves_pivotalhestudy (Xifaxan 3)

A line chart comparing the proportion of patients without HE-related hospitalization over time (days post-randomization) between XIFAXAN and placebo groups. The chart includes a hazard ratio, confidence interval, and p-value indicating statistical analysis results.*

FDA Label Image

Salix-logo (Xifaxan 4)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.